Lactylation in cardiovascular diseases (CVDs) The involvement of lactylation in the pathogenesis of CVDs, particularly atherosclerosis and myocardial infarction, as well as in conditions such as vascular calcification, neointimal hyperplasia, pulmonary hypertension, heart failure, and radiation-induced heart damage (RIHD), is becoming increasingly elucidated
doi: 10.4049/jimmunol.173.1.285
*Correspondence: Yi Hua, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
doi: 10.1007/s00203-022-03037-y 152 KovE.TkovZ.BhideK.KulkarniA.Jimnez-MunguaI.MertinkovP.et al
Most iv therapy sessions last 30 to 45 minutes